Alexion Pharmaceuticals said it has named an interim chief executive and a new chief financial officer as the company’s top leadership abruptly stepped down amid an investigation into improper sales practices.
from WSJ.com: US Business http://ift.tt/2gwKsVO
via IFTTT
No comments:
Post a Comment